Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders: A strengths, weaknesses, opportunities, and threats analysis and illustration

Abraham Rudnick; David Roe

doi:10.1080/15504263.2012.723314

Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders: A strengths, weaknesses, opportunities, and threats analysis and illustration

Abraham Rudnick, David Roe

Department of Community Mental Health

Research output: Contribution to journal › Comment/Debate

Original language	English
Pages (from-to)	333-336
Number of pages	4
Journal	Journal of Dual Diagnosis
Volume	8
Issue number	4
DOIs	https://doi.org/10.1080/15504263.2012.723314
State	Published - 1 Nov 2012

Bibliographical note

Funding Information:
Dr. Rudnick has received research and development related financial support from Astra Zeneca, Eli Lilly, Janssen-Ortho, Mylan, and Novartis, manufacturers of psychotropic medications, in order to advance mental health care. He has also co-received research and development related financial support from Telus and Microsoft, communication and electronic industry companies, in order to advance mental healthcare. Dr. Roe identifies no involvement with private or related industry.

ASJC Scopus subject areas

Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/15504263.2012.723314

Cite this

@article{165fb12f64d14e5b8d3a5356e0c608de,

title = "Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders: A strengths, weaknesses, opportunities, and threats analysis and illustration",

author = "Abraham Rudnick and David Roe",

note = "Funding Information: Dr. Rudnick has received research and development related financial support from Astra Zeneca, Eli Lilly, Janssen-Ortho, Mylan, and Novartis, manufacturers of psychotropic medications, in order to advance mental health care. He has also co-received research and development related financial support from Telus and Microsoft, communication and electronic industry companies, in order to advance mental healthcare. Dr. Roe identifies no involvement with private or related industry.",

year = "2012",

month = nov,

day = "1",

doi = "10.1080/15504263.2012.723314",

language = "English",

volume = "8",

pages = "333--336",

journal = "Journal of Dual Diagnosis",

issn = "1550-4263",

publisher = "Routledge",

number = "4",

}

Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders: A strengths, weaknesses, opportunities, and threats analysis and illustration. / Rudnick, Abraham; Roe, David.
In: Journal of Dual Diagnosis, Vol. 8, No. 4, 01.11.2012, p. 333-336.

Research output: Contribution to journal › Comment/Debate

TY - JOUR

T1 - Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders

T2 - A strengths, weaknesses, opportunities, and threats analysis and illustration

AU - Rudnick, Abraham

AU - Roe, David

N1 - Funding Information: Dr. Rudnick has received research and development related financial support from Astra Zeneca, Eli Lilly, Janssen-Ortho, Mylan, and Novartis, manufacturers of psychotropic medications, in order to advance mental health care. He has also co-received research and development related financial support from Telus and Microsoft, communication and electronic industry companies, in order to advance mental healthcare. Dr. Roe identifies no involvement with private or related industry.

PY - 2012/11/1

Y1 - 2012/11/1

UR - http://www.scopus.com/inward/record.url?scp=84869803422&partnerID=8YFLogxK

U2 - 10.1080/15504263.2012.723314

DO - 10.1080/15504263.2012.723314

M3 - Comment/Debate

AN - SCOPUS:84869803422

SN - 1550-4263

VL - 8

SP - 333

EP - 336

JO - Journal of Dual Diagnosis

JF - Journal of Dual Diagnosis

IS - 4

ER -

Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders: A strengths, weaknesses, opportunities, and threats analysis and illustration

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this